PharmaVoice 100: Page 6

  • A portrait of Dr. Rich Christie framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Rich Christie
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Dr. Rich Christie

    Driven by an enthusiasm for invention and a connection between scientific expertise and patient outcomes, the AiCure chief medical officer looks to nurture AI-powered technology.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Rosalind Brewer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rosalind Brewer
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Rosalind Brewer

    The CEO of Walgreens Boots Alliance is transforming the pharmacy powerhouse into a major new player in the healthcare space.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Sally Allain framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sally Allain
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Sally Allain

    The newest location for Johnson & Johnson Innovation’s incubator JLABS is in Washington, D.C., and the head of the cutting-edge space is bringing a diverse set of disruptive companies together.

    By • Sept. 6, 2022
  • A portrait of Samantha Singer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Samantha Singer
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Samantha Singer

    Abata’s CEO is stepping into the ring to fight for patients with progressive MS and other autoimmune disorders.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Sarah Hersey framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sarah Hersey
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Sarah Hersey

    At Bristol Myers Squibb, Sarah Hersey challenges the norm — and herself — to continually bring the best solutions to patients as vice president of translational sciences and diagnostics.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Sastry Chilukuri framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sastry Chilukuri
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Sastry Chilukuri

    The co-CEO of Medidata is ushering in the next generation of clinical trial advancements, making research easier and more patient-focused than ever before.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Scott Gray framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Scott Gray
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Scott Gray

    The CEO, founder and president of Clincierge is championing diversity and inclusion within the company and beyond.

    By • Sept. 6, 2022
  • A portrait of Sebastian Guth framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sebastian Guth
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Sebastian Guth

    Bayer Pharmaceuticals’ president, Americas Region, is driving equality efforts both within the company and for patients.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Shanthi Ganeshan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Shanthi Ganeshan
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Shanthi Ganeshan

    The longtime regulatory pro has used innovative strategies to deliver emerging oncology therapies to patients from her position as head of regulatory affairs at Stemline.

    By • Sept. 6, 2022
  • A portrait of Simba Gill framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Simba Gill
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Simba Gill

    The CEO of Evelo Biosciences is going where no one else in biotech has gone before.

    By • Sept. 6, 2022
  • A portrait of Dr. Stephen Dale framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Stephen Dale
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Dr. Stephen Dale

    The CMO at Kura Oncology, a clinical-stage biopharma company, is charting a new course to deliver on the promise of precision medicine in oncology.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Steven Steinhubl framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Steven Steinhubl
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Steven Steinhubl

    The chief medical officer at physIQ is working at the intersection of healthcare, clinical trials and technology to deliver better, faster and more accurate treatments to patients around the globe.

    By Karissa Waddick • Sept. 6, 2022
  • A portrait of Dr. Tania Small framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Tania Small
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Dr. Tania Small

    GSK’s medical oncology head is paving the way for patient-driven drug development and more equitable care.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Trishna Bharadia framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Trishna Bharadia
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Trishna Bharadia

    As a patient advocate, The Spark Global’s owner is transforming how pharma companies approach patient centricity.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Vincent Keunen framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Vincent Keunen
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Vincent Keunen

    With his unique platform, the  has built a bridge between patients, physicians and researchers around the world.  

    By • Sept. 6, 2022
  • A portrait of WeiQing Zhou framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by WeiQing Zhou
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: WeiQing Zhou

    The COO has launched two jewels in the biotech world that complement each other while serving broader innovation goals throughout the industry. 

    By • Sept. 6, 2022
  • A portrait of Dr. Yvonne Greenstreet framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Yvonne Greenstreet
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Dr. Yvonne Greenstreet

    The CEO of Alnylam — a leader in RNAi therapies — has the company at the top of its game scientifically and culturally.

    By PharmaVoice staff • Sept. 6, 2022
  • An illustration of stacked glowing silhouettes.
    Image attribution tooltip

    Illustration: Matthieu Bourel for Industry Dive

    Image attribution tooltip
    PharmaVoice 100

    The 2022 PharmaVoice 100

    From standout executives to R&D pioneers — this year’s class of honorees is defining the next era of leadership.

    By PharmaVoice staff • Sept. 6, 2022
  • Taren Grom, editor-in-chief emeritus, PharmaVoice
    Image attribution tooltip

    Permission granted by Taren Grom.

    Image attribution tooltip
    PharmaVoice 100

    The story behind the PharmaVoice 100

    Taren Grom, our founding editor and the feature’s originator, explains how the coveted PharmaVoice 100 awards got its start and what makes it stand out in the industry.

    By • Aug. 23, 2022
  • Teresa Bitetti Takeda Oncology
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Takeda Oncology’s Teresa Bitetti

    Upon joining Takeda Pharmaceuticals as president of the global oncology unit, Teresa Bitetti had two important goals: to transform the business and create greater synergies between commercial and R&D operations.

    By • Aug. 17, 2022
  • A person holds a magnet pointed at multi-colored wooden figures of people sitting on dark wood-grain table.
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip
    Making Moves

    Making moves: Agios, BeiGene, Biocom California and more announce new key hires

    The latest executive personnel changes from around the industry.

    By Karissa Waddick • July 18, 2022
  • Kerrie Brady head shot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: OcuTerra Therapeutics' Kerrie Brady

    The serial entrepreneur and now head of OcuTerra explains why taking risks in pharma pays off.

    By • June 1, 2022
  • Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma
    Image attribution tooltip

    Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees. 

    Image attribution tooltip
    Opinion

    Why 'soft' skills matter in the new era of leadership

    Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.

    By • May 12, 2022
  • This week's Woman of the Week Michelle Marlborough of AiCure shares her journey and leadership lessons.
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: AiCure's Michelle Marlborough

    As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.

    By • May 11, 2022
  • Image attribution tooltip

    Sangamo Therapeutics

    Image attribution tooltip
    Q&A // Biotech Spotlight

    Sangamo has its finger on the next evolution of gene editing

    Sangamo Therapeutics' CEO Sandy Macrae is bullish on his company’s ability to transform the genomic medicine arena.

    By • March 31, 2022